Analysis of Brain Activity to Uncover Brain-behavior Relationships Related to Therapy Outcomes in Aphasia

Sponsor
Penn State University (Other)
Overall Status
Recruiting
CT.gov ID
NCT03550092
Collaborator
(none)
22
1
1
56.2
0.4

Study Details

Study Description

Brief Summary

Aphasia is a loss of language due to stroke or other brain injury. Word-finding in conversation is a universal and persistent difficulty in aphasia. While several techniques exist to improve word-finding in aphasia, it is unclear how the brain changes in response to behavioral therapy. In this study, persons with aphasia will receive behavioral therapy aimed at helping them to be more successful at finding words. Twenty therapy sessions will be provided in a 10-week period. Each therapy session will last about 2 hours and will include a variety of language tasks. Prior to beginning word-finding therapy, each participant will receive two fMRI scans, spaced 10 weeks apart. After finishing therapy, each participant will receive two additional fMRI scans, spaced 10 weeks apart. For a portion of the MRI scan, participants will complete language tasks. The purpose of these fMRI scans is to measure brain changes that may occur due to successful behavioral therapy. The hypotheses are as follows: First, that the behavioral therapy will improve word-finding as it has been shown to do in the past. Second, that the brain will change in a couple of different ways. It is expected that the network of regions that support word-finding will be more connected and work together more efficiently after therapy. It is also expected that the networks of regions that support other aspects of cognitive function, such as attention and executive function, will also be more connected and work together more efficiently.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Abstract Semantic Association Network Training (AbSANT)
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
22 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Application of Graph Theory to Both Resting-state and Task-based fMRI Data to Uncover Brain-behavior Relationships Related to Therapy Outcomes in Aphasia
Actual Study Start Date :
Sep 25, 2018
Anticipated Primary Completion Date :
Dec 1, 2022
Anticipated Study Completion Date :
Jun 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Aphasia

Abstract Semantic Association Network Training (AbSANT) Each session will be 2 hours long and will occur twice each week for a total of 20 sessions.

Behavioral: Abstract Semantic Association Network Training (AbSANT)
In each session, the participant will be asked to categorize words, choose/discuss semantic features for each word that accurately describe the word, and generate as many words as possible within a category.
Other Names:
  • Semantic word-finding therapy
  • Semantic Feature Analysis/Verification
  • Outcome Measures

    Primary Outcome Measures

    1. Therapy Effect Size: Change in word generation performance from pre- to post-treatment measured using a version of Cohen's d [At baseline and at approximately 10 weeks (i.e., the end of therapy)]

      The mean of the baseline scores is subtracted from the mean of the post-treatment scores, and then divided by the standard deviation (SD) of the baseline scores. 6.5-8 is considered a small effect size, 8-9.5 is medium, and above 9.5 is large.

    2. Change in fMRI activation patters from pre- to post-treatment [At baseline and at approximately 10 weeks (i.e., the end of therapy)]

      Blood-oxygen-level-dependent MRI signal measured during task and rest and subjected to statistical tests of significant change from pre- to post-treatment.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    1. Diagnosis of aphasia

    2. Sustained stroke more than 6 months prior to consent

    3. Right-handed

    4. Native speakers of English

    5. Completed at least a high school education

    6. Normal or corrected-to-normal vision and hearing

    7. Provide written informed consent

    8. Participants will be medically stable and at least wheelchair ambulatory at the time of participation with uncompromised use of the left hand

    Exclusion Criteria:
    1. History of degenerative neurological disorders (e.g., Alzheimer's disease), acquired neurological disorders other than aphasia from stroke (e.g., traumatic brain injury), developmental neurological disorders (e.g., autism), or psychiatric disorders

    2. An active medical condition that could compromise participation (e.g., cancer undergoing acute treatment)

    3. Not safe to enter the bore of the magnet (e.g., pacemaker)

    4. Taking medications that are known to exert significant effects on cognitive processes

    5. Pregnancy or possibility of pregnancy

    6. Do not meet the above inclusionary criteria

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Hershey Medical Campus Hershey Pennsylvania United States 17033

    Sponsors and Collaborators

    • Penn State University

    Investigators

    • Principal Investigator: Chaleece W Sandberg, Ph.D., The Pennsylvania State University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Chaleece Sandberg, Assistant Professor, Penn State University
    ClinicalTrials.gov Identifier:
    NCT03550092
    Other Study ID Numbers:
    • 1R21DC016708-01A1
    First Posted:
    Jun 8, 2018
    Last Update Posted:
    Dec 23, 2021
    Last Verified:
    Dec 1, 2021
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Chaleece Sandberg, Assistant Professor, Penn State University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Dec 23, 2021